- Home
- WHWK vs CEE Comparison
WHWK vs CEE Comparison
Compare WHWK & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- CEE
- Stock Information
- Founded
- WHWK 2007
- CEE 1990
- Country
- WHWK United States
- CEE Germany
- Employees
- WHWK N/A
- CEE N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- WHWK Health Care
- CEE Finance
- Exchange
- WHWK Nasdaq
- CEE Nasdaq
- Market Cap
- WHWK 95.2M
- CEE 105.5M
- IPO Year
- WHWK N/A
- CEE N/A
- Fundamental
- Price
- WHWK $2.31
- CEE $15.61
- Analyst Decision
- WHWK
- CEE
- Analyst Count
- WHWK 0
- CEE 0
- Target Price
- WHWK N/A
- CEE N/A
- AVG Volume (30 Days)
- WHWK 5.1M
- CEE 22.0K
- Earning Date
- WHWK 11-15-2025
- CEE 01-01-0001
- Dividend Yield
- WHWK N/A
- CEE 3.86%
- EPS Growth
- WHWK N/A
- CEE N/A
- EPS
- WHWK N/A
- CEE N/A
- Revenue
- WHWK $21,596,000.00
- CEE N/A
- Revenue This Year
- WHWK N/A
- CEE N/A
- Revenue Next Year
- WHWK N/A
- CEE N/A
- P/E Ratio
- WHWK N/A
- CEE N/A
- Revenue Growth
- WHWK N/A
- CEE N/A
- 52 Week Low
- WHWK $1.39
- CEE $7.80
- 52 Week High
- WHWK $3.81
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- WHWK 56.25
- CEE 49.54
- Support Level
- WHWK $1.87
- CEE $14.91
- Resistance Level
- WHWK $2.72
- CEE $16.07
- Average True Range (ATR)
- WHWK 0.31
- CEE 0.46
- MACD
- WHWK 0.04
- CEE 0.07
- Stochastic Oscillator
- WHWK 25.26
- CEE 62.98
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.